business

Healthcare M&A Set for Record-Breaking Run Into Late 2024

PwC forecasts healthcare merger and acquisition activity will sustain record momentum through the second half of the year.

Healthcare mergers and acquisitions are on track to maintain record-setting pace through the second half of 2024, according to a new forecast from PwC, signaling sustained dealmaking appetite across one of the economy's largest sectors despite broader macroeconomic headwinds.

PwC's assessment points to enduring momentum in healthcare consolidation, driven by strategic buyers and private equity players seeking scale, cost efficiencies, and expanded service capabilities. The outlook suggests deal volume and value metrics that already reached historic highs in the first half are unlikely to retreat significantly as the year closes out.

Read more TikTok and YouTube Reshape How Fans Watch Sports →

The healthcare sector has long been a magnet for M&A activity, but the current cycle stands out for its breadth — spanning hospital systems, physician groups, health technology, and pharmaceutical services. Analysts broadly attribute the durability of dealmaking to structural pressures including labor cost inflation, reimbursement complexity, and the accelerating shift toward value-based care models that reward scale.

For investors and executives watching the space, PwC's projection carries meaningful implications. Companies positioned as acquisition targets may see heightened interest from strategic and financial buyers alike, while larger incumbents face pressure to pursue transformative deals before the window narrows or regulatory scrutiny intensifies. The Federal Trade Commission has signaled increased vigilance over healthcare consolidation, adding a layer of uncertainty even as deal pipelines remain full.

The sustained M&A environment reflects both opportunity and urgency in a sector undergoing rapid transformation. Whether activity can genuinely extend at record levels will depend on financing conditions, regulatory outcomes, and the strategic calculus of key players in the months ahead. Continue reading at SeekingAlpha.

Continue reading at SeekingAlpha →

Frequently Asked Questions

Q.What is driving record healthcare M&A activity in 2024?

PwC's forecast points to sustained dealmaking appetite across the healthcare sector, with strategic buyers and private equity seeking scale and cost efficiencies amid structural pressures like labor cost inflation and value-based care shifts.

Q.Will healthcare M&A activity continue through the second half of 2024?

According to PwC, record-setting healthcare M&A momentum is expected to extend through the second half of 2024, suggesting deal volume and value are unlikely to retreat significantly.

Q.How does regulatory scrutiny affect healthcare M&A deals?

The Federal Trade Commission has signaled increased vigilance over healthcare consolidation, which adds uncertainty to the deal environment even as pipelines remain active.

More in business →